Irreversible Electroporation Ablation Market

In 2026, tumor ablation accounts for 37.2% of the irreversible electroporation ablation market by application. Hospitals lead the end-user category with a 53.0% share, reflecting multidisciplinary resources, anesthesia support, imaging capabilities, and specialist teams required for complex irreversible electroporation procedures across oncology treatment pathways.